Insider · CIK 0001435183

Kong Garheng

Reports to the SEC for 10 companies · CHICAGO, IL

sec.gov

Transactions

Companies

Filings

CIK

0001435183

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+33K sh	$6.15	+$203K	32,996
2026-06-04	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+24.2K sh	—	—	238,337
2026-02-11	LHLABCORP HOLDINGS INC.M Exercise/Conversion	Director	MExercise/Conversion	+897 sh	—	—	13,739
2026-02-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−897 sh	—	—	773
2026-02-10	LHLABCORP HOLDINGS INC. · Restricted Stock UnitA Award	Director	AAward	+773 sh	—	—	1,670
2025-06-04	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+50K sh	—	—	214,144
2025-02-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitA Award	Director	AAward	+897 sh	—	—	897
2025-02-06	LHLABCORP HOLDINGS INC.M Exercise/Conversion	Director	MExercise/Conversion	+944 sh	—	—	12,842
2025-02-06	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−944 sh	—	—	0
2024-06-05	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+50K sh	—	—	164,144
2024-03-15	XERSXeris Biopharma Holdings, Inc.J Other	Director	JOther	+6,474 sh	—	—	114,144
2024-02-07	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−947 sh	—	—	944
2024-02-07	LHLABCORP HOLDINGS INC.M Exercise/Conversion	Director	MExercise/Conversion	+947 sh	—	—	11,898
2024-02-06	LHLABCORP HOLDINGS INC. · Restricted Stock UnitA Award	Director	AAward	+944 sh	—	—	1,891
2023-06-07	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+42.5K sh	—	—	107,670
2023-03-24	VEROVenus Concept Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2023-02-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−742 sh	—	—	849
2023-02-11	LHLABCORP HOLDINGS INC.M Exercise/Conversion	Director	MExercise/Conversion	+742 sh	—	—	10,951
2023-02-07	LHLABCORP HOLDINGS INC. · Restricted Stock UnitA Award	Director	AAward	+849 sh	—	—	1,591
2023-01-04	ALIMERA SCIENCES INCStock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2022-11-18	VEROVenus Concept Inc. · Voting Convertible Preferred StockP Purchase	Director	PPurchase	+335K sh	$2.00	+$670K	335,000
2022-06-08	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-06-08	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+15K sh	—	—	65,170
2022-03-25	VEROVenus Concept Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-02-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitA Award	Director	AAward	+742 sh	—	—	742
2022-02-02	LHLABCORP HOLDINGS INC.M Exercise/Conversion	Director	MExercise/Conversion	+771 sh	—	—	10,209
2022-02-02	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−771 sh	—	—	0
2021-12-15	VEROVenus Concept Inc.P Purchase	Director	PPurchase	+1.6M sh	$1.25	+$2M	6,795,621
2021-11-02	ALIMERA SCIENCES INCStock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2021-10-05	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+50.2K sh	—	—	50,170
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31.4K sh	—	—	31,360
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31.4K sh	—	—	31,360
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,357 sh	—	—	7,357
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.6K sh	—	—	19,600
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.6K sh	—	—	19,600
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,357 sh	—	—	7,357
2021-10-05	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+50.2K sh	—	—	50,170
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31.4K sh	—	—	31,360
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31.4K sh	—	—	31,360
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31.4K sh	—	—	31,360
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31.4K sh	—	—	31,360
2021-10-05	Strongbridge Biopharma plcStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−154K sh	—	—	0
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.7K sh	$2.37	+$46.6K	19,650
2021-10-05	Strongbridge Biopharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−64K sh	—	—	0
2021-10-01	Strongbridge Biopharma plcF Tax Payment	Director	FTax Payment	−17.8K sh	$2.06	−$36.6K	63,993
2021-05-18	Strongbridge Biopharma plcA Award	Director	AAward	+40K sh	—	—	81,756
2021-05-14	Strongbridge Biopharma plcF Tax Payment	Director	FTax Payment	−19.2K sh	$2.35	−$45.1K	41,756
2021-03-26	VEROVenus Concept Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-02-04	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−986 sh	—	—	771
2021-02-04	LHLABCORP HOLDINGS INC.M Exercise/Conversion	Director	MExercise/Conversion	+986 sh	—	—	9,438

Recent filings

Accepted (ET)
Jun 54
Kong Garheng0001867096-26-000041
SEC(opens sec.gov)
Feb 134
Kong Garheng0000920148-26-000074
SEC(opens sec.gov)
Feb 124
Kong Garheng0000920148-26-000059
SEC(opens sec.gov)
Jun 44
Kong Garheng0001867096-25-000106
SEC(opens sec.gov)
Feb 134
Kong Garheng0001127602-25-004517
SEC(opens sec.gov)
Feb 104
Kong Garheng0001127602-25-003707
SEC(opens sec.gov)
Jun 54
Kong Garheng0001867096-24-000104
SEC(opens sec.gov)
Apr 14
Kong Garheng0001867096-24-000041
SEC(opens sec.gov)
Feb 84
Kong Garheng0001127602-24-003889
SEC(opens sec.gov)
Jun 74
Kong Garheng0001867096-23-000101
SEC(opens sec.gov)
Mar 284
Kong Garheng0001362118-23-000021
SEC(opens sec.gov)
Feb 144
Kong Garheng0001127602-23-005110
SEC(opens sec.gov)
Feb 94
Kong Garheng0001127602-23-004134
SEC(opens sec.gov)
Jan 64
Kong Garheng0001474506-23-000008
SEC(opens sec.gov)

Companies

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607